RNA Sequencing of Solid and Cystic Lesions of the Pancreas
Information source: Oregon Health and Science University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pancreas Cyst; Pancreas Mass
Intervention: pancreas biopsy (Procedure)
Phase: N/A
Status: Enrolling by invitation
Sponsored by: Oregon Health and Science University
Summary
The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may
be benign, precancerous, or cancer. Current tests such as cytology (looking under a
microscope) and tumor markers do not always give us the answer. The investigators are
looking for genetic markers on biopsy specimens from the pancreas that will give us a better
test for diagnosis. This study is only for diagnosing these lesions. The investigators are
not treating any patients.
Clinical Details
Official title: RNA Sequencing of Solid and Cystic Lesions of the Pancreas
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Gene classifier that will classify lesions as benign or malignant with 95% certainty
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- greater than 18 years old,
- not pregnant,
- referred for endoscopic ultrasound,
- have a cyst or mass of the pancreas needing diagnosis.
Exclusion Criteria:
- pregnant,
- less than age 18,
- no mass or cyst found.
Locations and Contacts
Oregon Health and Science University, Portland, Oregon 97239, United States
Providence St Vincent Hospital, Portland, Oregon 97229, United States
Additional Information
Starting date: December 2012
Last updated: October 14, 2014
|